250 mg/2 mL
Trade Name
Ebglyss
Solution for injection
Request Type
Registration
Drug Type
Biological Drug
Approval Date
SFDA Approved Use
It is used for the treatment of adult and adolescent patients 12 years of age and older with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable. It can be used with or without topical corticosteroids.